BPC-157 Arginate vs Wolverine — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
BPC-157 Arginate is the arginine salt form of BPC-157, identical in the GEPPPGKPADDAGLV peptide sequence but with improved water solubility, aqueous stability, and oral bioavailability. The arginate counterion buffers GI microenvironmental pH, reducing acid-catalyzed peptide degr...
Calculate BPC-157 Arginate dose →Wolverine is a research peptide blend combining BPC-157 (5 mg) and TB-500 (5 mg) in a single vial. BPC-157 drives localized tissue repair and gut protection via angiogenesis; TB-500 promotes systemic cell migration and actin remodeling. Together they target overlapping healing pa...
Calculate Wolverine dose →| Parameter | BPC-157 Arginate | Wolverine |
|---|---|---|
| Category | Healing & Recovery | Healing & Recovery |
| Research | Extensively Studied | Research Blend |
| Half-Life | 4–6 hours | BPC-157: 4-6 h; TB-500: ~5 days |
| Typical Dose | 250–500 µg | 500-1,000 µg |
| Frequency | Once or twice daily | 2-3x per week |
| Route | Oral / Subcutaneous | Subcutaneous |
| FDA Status | Not Approved | Not Approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.